Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学DLBCL CAR-T and Bispecific Research

Caron Jacobson

MD, MMSc

🏢Dana-Farber Cancer Institute🌐USA

Medical Director, Immune Effector Cell Therapy Program

48
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Caron Jacobson is a leading immune effector cell therapy expert who has contributed to lisocabtagene maraleucel development through the TRANSCEND program. Her work on outpatient CAR-T administration and refined toxicity grading has improved the safety and accessibility of cellular therapy. She leads clinical programs integrating CAR-T and bispecific antibodies for lymphoma.

Share:

🧪Research Fields 研究领域

Liso-cel development
TRANSCEND trials
CAR-T toxicity grading
Immune effector cells
Outpatient CAR-T

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Caron Jacobson 的研究动态

Follow Caron Jacobson's research updates

留下邮箱,当我们发布与 Caron Jacobson(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment